DOWN

Featured image by Eoneren/Getty Images

Leveraged Loans

How low can credit spreads go? Hologic’s mega LBO tests the limit

A deal of this magnitude is finding a welcome reception from loan investors hungry for net supply.

Hologic this week wrapped up the broadly syndicated loan portion of a broader financing package supporting its LBO by Blackstone and TPG Capital, cementing its place as one of the largest buyout financings on record and drawing comparisons to another jumbo buyout deal, Medline Industries.

Following some sizing adjustments ahead of pricing, financing for the medical technology company comprises term loan B tranches totaling $7.25 billion and €1.3 billion (roughly $1.5 billion equivalent), a $1.25 billion term loan A, a privately placed second-lien term loan totaling $1.5 billion, and an undrawn $750 million revolver.

That combined total of $12.27 billion places Hologic as the fifth-largest LBO debt financing since the Global Financial Crisis (including privately placed debt) and the second-largest since Medline Industries in 2021, another borrower from the healthcare sector that also recently completed one of the largest IPOs for a PE-backed company. Excluding privately placed debt, Hologic is the sixth-largest financing post-GFC at $10.77 billion.

Looking just at institutional debt over the past five years, Hologic eclipses Medline to take the top slot as the largest LBO financing at $8.77 billion equivalent across its dollar and euro tranches. The dollar tranche alone, at $7.25 billion, is the largest single tranche issued in the US for an LBO since Medline’s $7.27 billion TLB in 2021.

A deal of this magnitude is finding a welcome reception from loan investors hungry for net supply. Last year, sponsors financed $59.4 billion of buyouts in the broadly syndicated loan market, slightly lagging 2024 levels and 27% below the 10-year average. Thanks to strong demand, Hologic rejiggered its credit package during syndication, carving out more debt for US institutional investors while cutting the size of the amortizing term loan. In addition, the spread on the dollar tranche was cut from the initial price talk of S+275-300 to S+225. This marks the tightest spread for any buyout of a B+/B1 borrower since 2007.

Similarly, MacLean Power Systems (MPS) is currently in market with a $2.01 billion term loan B to support the acquisition of the business by Power Grid Components, a portfolio company of Blackstone Energy Transition Partners. Investors are being told to expect facility ratings of B/B2 and corporate ratings of B/B3. Price talk for the seven-year TLB is S+275-300, the tightest level for any B/B3 LBO in eight years.

In the healthcare sector, Hologic is the fourth-largest LBO transaction of all time, at roughly $18 billion. Medline’s 2021 transaction tops the list, at $34 billion, including about $16 billion of total new debt, followed by HCA Healthcare’s $33 billion ($22.5 billion of debt) in 2006.

Several LBO deals have rolled off the shadow loan calendar to start the new year, all of them offering swaths of new supply to a parched new-issue market. Like Hologic, deals for Finastra TCM, Hillenbrand, and MacLean Power Systems are from borrowers that do not already have institutional loans outstanding. There is more to come, including the massive financing backing the take-private buyout of Electronic Arts.

Featured image by Eoneren/Getty Images

Learn about our editorial standards.